The prognosis of patients with metastatic or advanced sarcomas is poor and there are few options for treatment. Several studies have shown that gemcitabine and docetaxel (GD) combination chemotherapy has antitumor activity against various subtypes of sarcoma. | Gemcitabine and docetaxel combination chemotherapy for advanced bone and soft tissue sarcomas Protocol for an open-label non-randomised Phase 2 study